Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia

Kazuhiro Takahashi, Shuichi Taniguchi, Koichi Akashi, Kazuma Fujimoto, Tunefumi Sibuya, Hiromi Ishibashi, Mine Harada, Yoshiyuki Niho

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

We have recently treated a case of autoimmune neutropenia in a 57-year-old male. Because neutropenia persisted despite the administration of prednisolone for 30 days, daily subcutaneous injection of human recombinant granulocyte colony-stimulating factor (rhG-CSF) at a dosage of 100 ug was started. Neutrophil count increased gradually and reached a plateau of 5,000/ul by day 25 after administration of rhG-CSF. This observation suggests that rhG-CSF is effective for the treatment of autoimmune neutropenia.

Original languageEnglish
Pages (from-to)95-98
Number of pages4
JournalActa Haematologica
Volume86
Issue number2
DOIs
Publication statusPublished - 1991

All Science Journal Classification (ASJC) codes

  • Hematology

Fingerprint Dive into the research topics of 'Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia'. Together they form a unique fingerprint.

Cite this